EUVIMEDEUVIMED entdecken
Open Access

TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma

Akansha M Shah iD, Lei Guo, Maria Gabriela Morales, Priscilla Jaichander iD, Kenian Chen, Huocong Huang iD, Karla Cano Hernandez iD, Lin Xu iD, Rhonda Bassel-Duby iD, Eric N Olson iD, Ning Liu iD

Science Advances · 2023

DOI: 10.1126/sciadv.ade8184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Akansha M Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Sarcoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyosarcoma (RMS) is a common soft tissue sarcoma in children that resembles developing skeletal muscle. Unlike normal muscle cells, RMS cells fail to differentiate despite expression of the myogenic determination protein MYOD. The TWIST2 transcription factor is frequently overexpressed in fusion-negative RMS (FN-RMS). TWIST2 blocks differentiation by inhibiting MYOD activity in myoblasts, but its role in FN-RMS pathogenesis is incompletely understood. Here, we show that knockdown of TWIST2 enables FN-RMS cells to exit the cell cycle and undergo terminal myogenesis. TWIST2 knockdown also substantially reduces tumor growth in a mouse xenograft model of FN-RMS. Mechanistically, TWIST2 controls H3K27 acetylation at distal enhancers by interacting with the chromatin remodelers SMARCA4 and CHD3 to activate growth-related target genes and repress myogenesis-related target genes. These findings provide insights into the role of TWIST2 in maintaining an undifferentiated and tumorigenic state of FN-RMS and highlight the potential of suppressing TWIST2-regulated pathways to treat FN-RMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaSarcomaHumansAnimalsMiceChromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticCell DifferentiationCell Line, TumorDNA HelicasesNuclear ProteinsTranscription FactorsRepressor ProteinsTwist-Related Protein 1

Substanzen

SMARCA4 protein, humanDNA HelicasesNuclear ProteinsTranscription FactorsTWIST2 protein, humanRepressor ProteinsTwist-Related Protein 1

Autor:innen und Institutionen

  • Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.

ORCID-Profile: Akansha M Shah, Priscilla Jaichander, Huocong Huang, Karla Cano Hernandez, Lin Xu, Rhonda Bassel-Duby, Eric N Olson, Ning Liu

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Shah, A. M., Guo, L., Morales, M. G., Jaichander, P., Chen, K., Huang, H., Cano Hernandez, K., Xu, L., Bassel-Duby, R., Olson, E. N., & Liu, N. (2023). TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Science Advances. https://doi.org/10.1126/sciadv.ade8184

Vancouver

Shah AM, Guo L, Morales MG, Jaichander P, Chen K, Huang H, et al. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Science Advances. 2023. doi:10.1126/sciadv.ade8184

BibTeX
@article{Shah2023,
  author = {Shah, Akansha M and Guo, Lei and Morales, Maria Gabriela and Jaichander, Priscilla and Chen, Kenian and Huang, Huocong and Cano Hernandez, Karla and Xu, Lin and Bassel-Duby, Rhonda and Olson, Eric N and Liu, Ning},
  title = {TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.ade8184}
}
Kostenlos starten →